| Antibody durability at 1 year after Sputnik V vaccination | Ver |
| Commentary: Role of Tocilizumab in Hospitalized COVID‑19 Patients | Ver |
| Criptocosis Diseminada en Paciente no HIV (2010) – Medicina | Ver |
| Detección de sars-cov-2 en contactos asintomáticos | Ver |
| Early High‑Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults | Ver |
| Early use of tocilizumab in hospitalized patients with severe COVID‑19 | Ver |
| Efectos de la administración de LPS en ratas macho sobre conducta sexual | Ver |
| Efectos de la inhibición de la hemoxigenasa sobre … adrenal de rata | Ver |
| Effectiveness of BBIBP‑CorV, BNT162b2 and mRNA‑1273 vaccines among children/adolescents during Omicron outbreak | Ver |
| Estimating COVID‑19 cases and outbreaks on‑stream through phone calls | Ver |
| Focos infecciosos y resistencia antibiótica en sala de Clínica Médica (2008) – Resumen Medicina Vol 68 SUPL I | Ver |
| Impacto de la pandemia Covid‑19 en indicadores de mortalidad, Provincia de Buenos Aires | Ver |
| INFLUENZA H1N1 – Experiencia en Htal Ramos Mejía (2010) | Ver |
| Longitudinal follow-up: Immunity to SARS‑CoV‑2 after Sputnik V | Ver |
| Longitudinal Study after Sputnik V Vaccination Shows Durable Neutralizing Antibodies | Ver |
| Persistence of antibodies IgG to SARS‑CoV2 in health care workers – Argentina | Ver |
| Plan estratégico de Salud Integral… Servicio Penitenciario Federal 2012-2015 – Documento oficial | Ver |
| Protection of homologous and heterologous boosters during Omicron outbreak | Ver |
| Risk factors for COVID‑19 mortality: The effect of convalescent plasma administration | Ver |
| Safety analysis of Covid‑19 vaccines in Buenos Aires Province – Revista Argentina de Medicina (jun 2021) | Ver |
| Seroprevalencia de anticuerpos contra SARS‑COV‑2 en barrios populares… (dic 2020) – Revista Margen | Ver |
| Sputnik V Vaccine Elicits Seroconversion and Neutralizing Capacity… – Cell Reports Medicine (ago 2021) | Ver |
| Surveillance and Seroprevalence: Evaluation of IgG antibodies… Villa Azul (sep 2020) – Preprint | Ver |
| Timing of convalescent plasma administration and 28‑day mortality in COVID‑19 pneumonia | Ver |